Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Lucia Raimondo"'
Publikováno v:
Revista de Enfermagem da UFPI, Vol 3, Iss 2 (2020)
DOI: https://doi.org/10.26694/reufpi.v3i2.1960 Objetivo: identificar o percurso de resiliência de mulheres em situação de violência conjugal. Metodologia:pesquisa descritiva de abordagem qualitativa, realizado em uma Delegacia da Mulher de um m
Externí odkaz:
https://doaj.org/article/a21eabe3ae2e432789ed91be30a2fbd8
Autor:
Eduarda Navroski Losso, Maria Lucia Raimondo, Mirella Moraes Oliveira, Alexandra Bittencourt Madureira, Thatiany Camargo Lins Tonatto, Leticia Dmyterko
Publikováno v:
Brazilian Journal of Development. 8:80152-80170
Trata-se de pesquisa quantitativa, realizada com dados de 526 mulheres, objetivando objetivo conhecer o perfil de mulheres vítimas de violência doméstica e dos atendidas em um Centro de Referência de Atendimento à Mulher em Situação de Violên
Autor:
C. Di Mauro, Lucia Raimondo, Lucia Nappi, R. Marciano, Bianca Maria Veneziani, C Fusciello, Valentina D’Amato, C. D'Amato, Roberto Bianco, R. Rosa, S. De Placido, Alberto Servetto, Luigi Formisano
Publikováno v:
British Journal of Cancer
Background:Cetuximab is the only targeted agent approved for the treatment of head and neck squamous cell carcinomas (HNSCC), but low response rates and disease progression are frequently reported. As the phosphoinositide 3-kinase (PI3K) and the mamm
Autor:
Lucia Raimondo, Sabino De Placido, Chiara Carlomagno, Chiara Alessandra Cella, Roberto Moretto, Alfonso De Stefano, Elide Matano
Publikováno v:
Anti-Cancer Drugs. 24:980-985
Pancreatic and biliary tract carcinomas are very chemoresistant. After a first-line treatment with a gemcitabine-based regimen, no second-line scheme is consolidated in clinical practice. The aim of this study was to evaluate the toxicity and the act
Autor:
Lucia Raimondo, Florian Lordick, Katja Sibylle Muehlberg, Chiara Alessandra Cella, Chiara Carlomagno, Alfonso De Stefano, Laura Attademo, Elide Matano, Roberto Moretto, Michele Arcopinto, Maria Gabrecht, Sabino De Placido, Maren Knoedler, Haiko Schloegl, Dario Bruzzese, Gertraud Stocker
Background: The awareness of venous thromboembolism (VTE) burden in ambulatory cancer patients is growing. Due to the heterogeneity in the individual risk profile, predictive risk scores have been proven to be useful in the identification of high-ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d387a3f0f29a12d741ca3dfdd8dc5be
http://hdl.handle.net/11588/571283
http://hdl.handle.net/11588/571283
Autor:
Piera Federico, Pasquale Rescigno, Giuseppe Di Lorenzo, Ciro Mainolfi, Rossella Di Trolio, Elide Matano, Giovannella Palmieri, Vincenzo Damiano, Carmine D'Aniello, Sabino De Placido, Lucia Raimondo, Carlo Buonerba
Publikováno v:
Anti-Cancer Drugs. 23:573-577
Guidelines on the treatment of metastatic squamous cell carcinoma of the penis are limited to a few prospective trials. Cisplatin-based regimens represent the standard of treatment with promising activity of taxanes. Recently, epidermal growth factor
Autor:
Livio Puglia, Giuseppe Di Lorenzo, Giovannella Palmieri, Lucia Nappi, Pasquale Rescigno, Elide Matano, Vincenzo Damiano, Carmine D'Aniello, Piera Federico, Antonella Petremolo, Lucia Raimondo
Publikováno v:
Open Journal of Urology. :83-86
Primary germ cell tumors of lung are extremely rare. The prognosis is usually poor, with various symptoms seriously affecting quality of life. In this paper we describe the unique case of a patient affected by an embryonal carcinoma of lung and a tes
Publikováno v:
Journal of Cancer Therapy. :281-284
Digital ischemia is a rare paraneoplastic phenomenon associated with various malignancies, especially adenocarci-nomas. We reported a case of digital ischemia onset during treatment with capecitabine + oxaliplatin, letrozole and epoetin-beta in a 75-
Autor:
Valentina D’Amato, Roberta De Rosa, Luigi Formisano, Lucia Raimondo, Roberto Bianco, Mario Giuliano, Sabino De Placido
Targeted therapies have been approved for various malignancies but the acquisition of resistance remains a substantial challenge in the clinical management of advanced cancers. Twenty-five per cent of breast cancers overexpress ErbB2/HER2, which conf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7a7f0656b443f0c14c8bcc01d83821
http://hdl.handle.net/11588/615670
http://hdl.handle.net/11588/615670
Autor:
Pasquale Rescigno, Elide Matano, Lucia Raimondo, Ciro Mainolfi, Piera Federico, Carlo Buonerba, Rossella Di Trolio, Carmine D?Aniello, Vincenzo Damiano, Giuseppe Di Lorenzo, PALMIERI, GIOVANNELLA, DE PLACIDO, SABINO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::92f3e59ee3627bf34d5eaf9d055fb5a0
http://hdl.handle.net/11588/569154
http://hdl.handle.net/11588/569154